| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62cf7a549d7a2737dcc6bc6e472afbe1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14f0968980e2510a2cc14ac26baebb88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75f4966cafe142b557de5f9acc221869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa13725132bcbc895d527a8a7324dcaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B40-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B40-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B30-06 |
| filingDate |
2012-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b68e42140c0f85ed949ad3124dc40f9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95b7449eff1678d3f19031758fd78aab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1661ce7b1eb58d3cebe6da1069ef427a |
| publicationDate |
2012-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012316321-A1 |
| titleOfInvention |
Methods for identifying markers for early-stage human cancer, cancer progression and recurrence |
| abstract |
A method is described to identify secreted proteins identified with stages of malignancy of cancer. The proteins are initially identified by trapping them with a fluorescent protein containing vector that can insert in any gene. The secreted proteins are initially identified by their fluorescence. Secreted proteins identifying tumors with specific degrees of malignancy are isolated to determine if they can serve as markers of cancer progression. |
| priorityDate |
2005-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |